Although PSMC1 did not score in the PC3 cells in the initial shRNA library screen, siRNA knockdown of PSMC1 impaired viability of PC3 cells, raising the possibility that these antiproliferative effects may not be specific to AR-positive prostate cancer cells (Figure S3). The gene discussed is PSMC1; the disease is prostate carcinoma.